These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22040787)

  • 21. Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
    Mori M; Tsukuda M; Horiuchi C; Matsuda H; Taguchi T; Takahashi M; Nishimura G; Komatsu M; Niho T; Sakuma N; Shibata K; Sugisaki S
    Auris Nasus Larynx; 2011 Dec; 38(6):724-9. PubMed ID: 21665394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
    Kawai N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
    Takemoto K; Hatano E; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Matsumura K; Zaima M; Toriguchi K; Tanabe K; Kitamura K; Seo S; Taura K; Endo K; Uemoto S; Higashi T
    Ann Nucl Med; 2014 May; 28(4):371-80. PubMed ID: 24599824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
    Nair VJ; MacRae R; Sirisegaram A; Pantarotto JR
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):312-8. PubMed ID: 24411602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of alteration 2-[fluorine-18]fluoro-2-deoxy-(D)-glucose uptake in the liver and skeletal muscles of patients with hyperthyroidism.
    Chen YK; Chen YL; Tsui CC; Wang SC; Cheng RH
    Acad Radiol; 2013 Oct; 20(10):1218-23. PubMed ID: 24029053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between survival and maximum standardized uptake value of liver metastases detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in patients with adenocarcinoma of unknown primary origin.
    Algin E; Ozet A; Gumusay O; Cetin B; Akdemir UO; Benekli M; Coskun U; Uner A; Kapucu O; Buyukberber S
    Ann Nucl Med; 2014 Nov; 28(9):891-6. PubMed ID: 25270711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT.
    Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M
    Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stepwise approach using metabolic volume and SUVmax to differentiate malignancy and dysplasia from benign colonic uptakes on 18F-FDG PET/CT.
    Oh JR; Min JJ; Song HC; Chong A; Kim GE; Choi C; Seo JH; Bom HS
    Clin Nucl Med; 2012 Jun; 37(6):e134-40. PubMed ID: 22614211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.
    Hong SP; Noh TS; Moon SH; Cho YS; Lee EJ; Choi JY; Kim BT; Lee KH
    Dig Dis Sci; 2014 Mar; 59(3):607-13. PubMed ID: 24326630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.
    Kurtipek E; Çayci M; Düzgün N; Esme H; Terzi Y; Bakdik S; Aygün MS; Unlü Y; Burnik C; Bekci TT
    Clin Nucl Med; 2015 Jun; 40(6):459-63. PubMed ID: 25742234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy.
    Stumpe KD; Renner-Schneiter EC; Kuenzle AK; Grimm F; Kadry Z; Clavien PA; Deplazes P; von Schulthess GK; Muellhaupt B; Ammann RW; Renner EL
    Infection; 2007 Feb; 35(1):11-8. PubMed ID: 17297583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Schmorl's nodes using F-18 FDG PET/CT.
    Lin CY; Chen HY; Ding HJ; Chen YK; Kao CH
    Clin Radiol; 2012 Nov; 67(11):e17-21. PubMed ID: 22608243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
    Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
    Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitis.
    Kim K; Kim SJ; Kim IJ; Kim BS; Pak K; Kim H
    Nucl Med Commun; 2011 Dec; 32(12):1155-61. PubMed ID: 21970834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT.
    Abikhzer G; Alabed YZ; Azoulay L; Assayag J; Rush C
    AJR Am J Roentgenol; 2011 Jan; 196(1):176-80. PubMed ID: 21178064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease.
    Shyn PB; Mortele KJ; Britz-Cunningham SH; Friedman S; Odze RD; Burakoff R; Goldberg JE; Erturk M; Silverman SG
    J Nucl Med; 2010 Dec; 51(12):1841-8. PubMed ID: 21078803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of ¹⁸F-fluoro-dexoxyglucose positron emission tomography/computed tomography in patients with adult-onset Still's disease: a seven-case series and review of the literature.
    Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2014 Jul; 24(4):645-50. PubMed ID: 24252024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
    Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
    Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.